New Technology Enhances Topical Delivery to Front and Back of the Eye

Kala Pharmaceuticals, Inc., says that its researchers will present preclinical data at the upcoming Controlled Release Society (CRS) 2013 Annual Meeting taking place July 21-24, 2013, in Honolulu, HI. The poster presentation will highlight the capability of Kala’s proprietary Mucosal-Penetrating Particle (MPP) technology to enhance topical drug delivery to the front and back of the eye. Read more.